08045804946
Send Inquiry
ZYCEVA 100MG TABS
2400.0 INR/Number
Product Details:
- Packaging Type Blister Pack or Strip
- Indication Primary treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC); metastatic pancreatic cancer in combination with gemcitabine
- Life Span 24 Months from manufacturing date
- Brand Name ZYCEVA
- Salt Composition Erlotinib Hydrochloride 100mg
- Origin of Medicine India
- Dosage Form Solid, Oral Tablet
- Click to View more
X
ZYCEVA 100MG TABS Price And Quantity
- 2400.0 INR/Number
- 1 Number
- Rash, diarrhea, anorexia, fatigue, dyspnea
- Hypersensitivity to Erlotinib or any excipients
- Zydus Cadila Healthcare Ltd.
- 100mg per tablet
- Prescription
- May interact with strong CYP3A4 inhibitors, proton pump inhibitors, and St John's Wort
- Antineoplastic Agent
- White to off-white
- India
- Round
- Oral
- Monitor for interstitial lung disease, hepatic and renal impairment, and gastrointestinal perforation
- Registered
ZYCEVA 100MG TABS Product Specifications
- 30 Tablets per box
- Blister Pack or Strip
- As prescribed by physician
- Adults
- Primary treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC); metastatic pancreatic cancer in combination with gemcitabine
- ZYCEVA
- 24 Months from manufacturing date
- Prescription Only
- Take on an empty stomach, at least 1 hour before or 2 hours after food
- Erlotinib Hydrochloride
- Erlotinib Hydrochloride 100mg
- Tablet
- Store below 25C, keep in a dry place, protect from light
- Anti-cancer (Kinase Inhibitor)
- India
- Solid, Oral Tablet
- 30 Tablets
- Adults with Non-Small Cell Lung Cancer (NSCLC) and Pancreatic Cancer
- Rash, diarrhea, anorexia, fatigue, dyspnea
- Hypersensitivity to Erlotinib or any excipients
- Zydus Cadila Healthcare Ltd.
- 100mg per tablet
- Prescription
- May interact with strong CYP3A4 inhibitors, proton pump inhibitors, and St John's Wort
- Antineoplastic Agent
- White to off-white
- India
- Round
- Oral
- Monitor for interstitial lung disease, hepatic and renal impairment, and gastrointestinal perforation
- Registered
ZYCEVA 100MG TABS Trade Information
- Cash Advance (CA), Cash in Advance (CID), Cash on Delivery (COD)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Western Europe, Australia, Central America, North America, South America, Eastern Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Erlotinib 100 mg.
- Mechanism of Action: The medication works by blocking the action of an abnormal protein called the epidermal growth factor receptor (EGFR), which is found on the surface of cancer cells and helps them grow and multiply. By inhibiting this protein, Zyceva helps slow the growth and spread of cancer cells.
- Uses:
- Non-small cell lung cancer (NSCLC): Used in patients with specific EGFR gene mutations, either as an initial therapy or after prior chemotherapy treatments.
- Pancreatic cancer: Used in combination with another cancer medicine, gemcitabine, to manage cancer that has spread to other parts of the body (metastatic stage).
- Administration: The tablet is taken orally, usually once daily on an empty stomach (at least one hour before or two hours after a meal). It should be swallowed whole with water and not crushed or chewed.
Key Benefits of ZYCEVA 100MG Tablets
ZYCEVA offers a targeted approach for treating advanced non-small cell lung cancer and metastatic pancreatic cancer by blocking specific protein signals that drive cancer cell growth. When used as prescribed, it may slow disease progression, offering patients improved outcomes. Its oral administration also provides convenience compared to injectable alternatives, making it suitable for outpatient management under regular medical supervision.
How to Use ZYCEVA Effectively
For optimal absorption, ZYCEVA tablets should be taken orally on an empty stomach-preferably at least one hour before or two hours after food. Patients must follow their physician's dosage instructions precisely. Regular monitoring is advised, particularly for any signs of lung, liver, or gastrointestinal complications. Consistent use as directed maximizes the drug's therapeutic value while minimizing the risk of side effects.
FAQ's of ZYCEVA 100MG TABS:
Q: How should I take ZYCEVA 100MG tablets?
A: Take ZYCEVA 100MG tablets on an empty stomach, at least one hour before or two hours after eating. Swallow the tablet whole with water, following your physician's prescribed dosage. Consistent administration at the same time each day is recommended.Q: What conditions is ZYCEVA prescribed for?
A: ZYCEVA is primarily prescribed for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC), and for metastatic pancreatic cancer when used in combination with gemcitabine.Q: When should I avoid taking ZYCEVA 100MG?
A: Avoid ZYCEVA if you have a known hypersensitivity to Erlotinib or any of the excipients in the tablet. Always inform your healthcare provider of any allergies or past adverse reactions before starting treatment.Q: Where should I store ZYCEVA tablets for maximum shelf life?
A: Store ZYCEVA below 25C in a dry place, protected from light. Keep tablets in their original blister packaging until use, and out of reach of children.Q: What common side effects should I watch for while using ZYCEVA?
A: Common side effects include rash, diarrhea, loss of appetite, fatigue, and shortness of breath. If you experience severe reactions or new symptoms, contact your doctor promptly.Q: How does ZYCEVA benefit cancer patients?
A: ZYCEVA targets and blocks certain growth signals in cancer cells, helping to slow or stop tumor progression. This can lead to longer progression-free survival and improved quality of life when taken as directed.Q: Can ZYCEVA interact with other medications?
A: Yes, ZYCEVA may interact with strong CYP3A4 inhibitors, proton pump inhibitors, and herbal supplements like St. John's Wort. Always inform your healthcare provider about all medications and supplements you are taking.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
